Search research articles
Contact Us
Filters
Showing results (691-700 of 726) with videos related to
Page
of 73
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 10, 2021
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
Felix C Saalfeld, Carina Wenzel, Petros Christopoulos, et al.
JCI Insight
|
October 5, 2018
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies
Elisa Ten Hacken, Rebecca Valentin, Fara Faye D Regis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2021
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
Xiuning Le, Hiroshi Sakai, Enriqueta Felip, et al.
Insects
|
June 26, 2024
Allele Frequencies of Genetic Variants Associated with Varroa Drone Brood Resistance (DBR) in <i>Apis mellifera</i> Subspecies across the European Continent
Regis Lefebre, Lina De Smet, Anja Tehel, et al.
Nature Immunology
|
June 22, 2018
Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses
Giorgio Napolitani, Prathiba Kurupati, Karen Wei Weng Teng, et al.
Nature Immunology
|
March 14, 2019
Publisher Correction: Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses
Giorgio Napolitani, Prathiba Kurupati, Karen Wei Weng Teng, et al.
Immunity
|
August 14, 2016
A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures
Michael Thomas Wong, David Eng Hui Ong, Frances Sheau Huei Lim, et al.
Nature Medicine
|
February 20, 2018
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler, Akihide Yoshimi, Rachel Darman, et al.
The New England Journal of Medicine
|
September 3, 2020
Capmatinib in <i>MET</i> Exon 14-Mutated or <i>MET</i>-Amplified Non-Small-Cell Lung Cancer
Jürgen Wolf, Takashi Seto, Ji-Youn Han, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2022
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions
Petros Christopoulos, Klaus Kluck, Martina Kirchner, et al.
Page
of 73
Search research articles
Search
Showing results (691-700 of 726) with videos related to
Sort By:
Page
of 73
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 10, 2021
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
Felix C Saalfeld, Carina Wenzel, Petros Christopoulos, et al.
JCI Insight
|
October 5, 2018
Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies
Elisa Ten Hacken, Rebecca Valentin, Fara Faye D Regis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2021
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice
Xiuning Le, Hiroshi Sakai, Enriqueta Felip, et al.
Insects
|
June 26, 2024
Allele Frequencies of Genetic Variants Associated with Varroa Drone Brood Resistance (DBR) in <i>Apis mellifera</i> Subspecies across the European Continent
Regis Lefebre, Lina De Smet, Anja Tehel, et al.
Nature Immunology
|
June 22, 2018
Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses
Giorgio Napolitani, Prathiba Kurupati, Karen Wei Weng Teng, et al.
Nature Immunology
|
March 14, 2019
Publisher Correction: Clonal analysis of Salmonella-specific effector T cells reveals serovar-specific and cross-reactive T cell responses
Giorgio Napolitani, Prathiba Kurupati, Karen Wei Weng Teng, et al.
Immunity
|
August 14, 2016
A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures
Michael Thomas Wong, David Eng Hui Ong, Frances Sheau Huei Lim, et al.
Nature Medicine
|
February 20, 2018
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler, Akihide Yoshimi, Rachel Darman, et al.
The New England Journal of Medicine
|
September 3, 2020
Capmatinib in <i>MET</i> Exon 14-Mutated or <i>MET</i>-Amplified Non-Small-Cell Lung Cancer
Jürgen Wolf, Takashi Seto, Ji-Youn Han, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2022
The impact of TP53 co-mutations and immunologic microenvironment on outcome of lung cancer with EGFR exon 20 insertions
Petros Christopoulos, Klaus Kluck, Martina Kirchner, et al.
Page
of 73